几丁质酶3样蛋白1通过雷帕霉素复合物1信号通路促进系统性硬化症内皮间质转化
该研究探讨几丁质酶3样蛋白1(CHI3L1)在系统性硬化症(SSc)内皮间质转化(EndoMT)中的作用及机制。皮肤免疫荧光证实SSc患者存在EndoMT及CHI3L1与内皮细胞共定位;体外实验显示CHI3L1促进人脐静脉内皮细胞EndoMT;博来霉素诱导SSc小鼠中抗CHI3L1抗体减轻血管病变和纤维化;机制涉及CHI3L1结合CD44受体激活Akt/mTORC1/S6激酶通路调控Snail和Slug;雷帕霉素可抑制该过程。
要点
- SSc患者皮肤中证实存在EndoMT且CHI3L1与内皮细胞共定位。
- CHI3L1通过结合CD44受体激活Akt/mTORC1/S6激酶通路促进EndoMT。
- 抗CHI3L1抗体在博来霉素诱导SSc小鼠中减轻血管病变和纤维化。
核心结论
- 本研究揭示CHI3L1促进SSc中EndoMT的新功能,并提示CHI3L1是SSc有前景的治疗靶点。
研究设计与样本
- 研究对SSc患者皮肤切片进行免疫染色检测EndoMT及CHI3L1表达模式。
- 体外用人脐静脉内皮细胞(HUVECs)以重组CHI3L1和抗CHI3L1抗体刺激探索CHI3L1对内皮细胞的影响。
- 体内用博来霉素(BLM)诱导SSc小鼠以抗CHI3L1抗体治疗观察血管病变和纤维化改善。
- 采用蛋白质组学探索CHI3L1诱导内皮细胞EndoMT的具体机制。
主要发现
- SSc患者皮肤切片免疫荧光证实EndoMT及CHI3L1与内皮细胞共定位。
- CHI3L1被证明促进HUVECs中EndoMT。
- BLM-SSc小鼠中抗CHI3L1抗体治疗显示SSc血管病变和纤维化减轻。
- CHI3L1主要通过结合内皮细胞CD44受体,激活下游Akt/mTORC1/S6激酶信号通路,调控EndoMT触发转录因子Snail和Slug。
- mTORC1抑制剂雷帕霉素给药显示抑制CHI3L1介导的EndoMT过程。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Systemic sclerosis (SSc) is a complicated autoimmune connective tissue disorder. Endothelial-to-mesenchymal transition (EndoMT) contributes to vasculopathy and fibrosis in SSc, yet its underlying mechanism remains to be elucidated. Here, we determined the role and mechanism of chitinase 3-like 1 (CHI3L1) in SSc EndoMT. METHODS: Skin sections were immunostained for detecting the EndoMT and the expression pattern of CHI3L1 in patients with SSc. Human umbilical vein endothelial cells (HUVECs) were stimulated with recombinant CHI3L1 and anti-CHI3L1 antibody (CHI3L1 Ab) to explore the effects of CHI3L1 on ECs in vitro. In vivo, the bleomycin (BLM)-induced SSc mice were treated with CHI3L1 Ab to investigate the improvement of vasculopathy and fibrosis. Furthermore, proteomics was conducted to explore the specific mechanism by which CHI3L1 induces EndoMT in ECs. RESULTS: Immunofluorescence staining of skin sections confirmed EndoMT and the co-localization of CHI3L1 and ECs in patients with SSc. Subsequently, CHI3L1 was demonstrated to facilitate EndoMT in HUVECs. Furthermore, treatment with CHI3L1 Ab in BLM-SSc mice showed alleviation in SSc vasculopathy and fibrosis. Mechanistically, CHI3L1 mediated EndoMT primarily by binding to the CD44 receptor on ECs, then activating the downstream Akt/mechanistic target of rapamycin complex 1 (mTORC1)/S6 kinase signaling pathway, thereby regulating the EndoMT trigger transcription factors Snail and Slug. Finally, administration of rapamycin, an mTORC1 inhibitor, has been shown to inhibit the CHI3L1-mediated EndoMT process. CONCLUSION: This research reveals a new function of CHI3L1 in facilitating EndoMT in SSc and highlights CHI3L1 as a promising therapeutic target for SSc.
引用
- Wang X, Han X, Yu J, et al. Chitinase 3-Like 1 Promotes Endothelial-to-Mesenchymal Transition in Systemic Sclerosis via Mechanistic Target of Rapamycin Complex 1 Signaling Pathway. Arthritis Rheumatol. 2025. PMID: 40799002. doi:10.1002/art.43356
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。